Answers are grounded in this paper and cite their sources.
WHO分類により骨髄異形成症候群/骨髄増殖性疾患myelodysplastic/myeloproliferative diseases (MDS) / (MPD) に分類されるPhiladelphia (Ph) 染色体陰性の非定型慢性骨髄性白血病atypical CML (aCML) 2例と慢性骨髄単球性白血病chronic myelomonocytic leukemia (CMML) 1例を経験した.aCMLの2症例は白血球増加,各成熟段階の顆粒球系細胞の増加,顆粒球の異形成を認めたが染色体異常は認めなかった.CA (cytosine arabinoside, aclacinomycin) 療法,interferon (IFN) -α,hydroxyurea (HU)
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: